Concepedia

Katharine L. Chu

KL

Statistics

Publications

31

Citations

2.8K

H-Index

23

Active since

2001

Affiliations

Abbott Fund(Current)

Abbott (United States)

AbbVie (United States)

Abbott (United Kingdom)

Discovery Laboratories (United States)

Katharine L. Chu is an author at Abbott Fund specializing in pharmacology, pain medicine, and neuroscience.

Publications per year

2001–2018

31

Publications

31

A-803467, a potent and selective Na <sub>v</sub> 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

Michael F. Jarvis, Prisca Honoré, Char‐Chang Shieh et al. · Proceedings of the National Academy of Sciences · 2007 · 523 citations · Full text

, , +17

A-317491, a novel potent and selective non-nucleotide antagonist of P2X <sub>3</sub> and P2X <sub>2/3</sub> receptors, reduces chronic inflammatory and neuropathic pain in the rat

Michael F. Jarvis, Edward C. Burgard, Steve McGaraughty et al. · Proceedings of the National Academy of Sciences · 2002 · 466 citations

, , +17

Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation

Jun Chen, Shailen K. Joshi, Stanley DiDomenico et al. · Pain · 2011 · 271 citations · Full text

, , +17

TRPA1 Modulation of Spontaneous and Mechanically Evoked Firing of Spinal Neurons in Uninjured, Osteoarthritic, and Inflamed Rats

Steve McGaraughty, Katharine L. Chu, Richard J. Perner et al. · Molecular Pain · 2010 · 194 citations · Full text

, , +17

Effects of A‐317491, a novel and selective P2X<sub>3</sub>/P2X<sub>2/3</sub> receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration

Steve McGaraughty, Carol T. Wismer, Chang Zhu et al. · British Journal of Pharmacology · 2003 · 178 citations · Full text

, , +17

1–5 of 31